Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 4/20 | 0.37 |
| ▸ | TACR1 | P25103 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GJA1 | P17302 | 1/20 | 0.32 |
| ▸ | GJB2 | P29033 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SELL | P14151 | 1/20 | 0.32 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.32 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.32 |
| ▸ | TACR2 | P21452 | 1/20 | 0.31 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2682317 | 0.93 | PDPK1 (0.38) | PDPK1MTORSLC6A2SSTR4TACR2 | |
| SCHEMBL3166119 | 0.93 | PDPK1 (0.38) | PDPK1MTORSLC6A2SSTR4TACR2 | |
| SCHEMBL7452769 | 0.88 | SLC5A2 (0.40) | LGALS3TACR1GJA1GJB2SELL | |
| SCHEMBL7997389 | 0.88 | SLC5A2 (0.40) | LGALS3TACR1GJA1GJB2SELL | |
| SCHEMBL7552425 | 0.88 | SLC5A2 (0.40) | LGALS3TACR1GJA1GJB2SELL | |
| SCHEMBL7555790 | 0.88 | SLC5A2 (0.40) | LGALS3TACR1GJA1GJB2SELL | |
| SCHEMBL18385956 | 0.87 | LGALS3 (0.38) | LGALS3TACR1PDPK1MTORSLC6A2 | |
| SCHEMBL584260 | 0.86 | TACR1 (0.38) | LGALS3TACR1NPC1RAB9APDPK1 | |
| SCHEMBL5942515 | 0.85 | PDPK1 (0.38) | LGALS3GJB2PDPK1MTORSLC6A2 | |
| SCHEMBL22046241 | 0.85 | PDPK1 (0.38) | LGALS3GJB2PDPK1MTORSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2417144-B1 | SYNTHESIS OF 2'-O-FUCOSYLLACTOSE | GLYCOM AS (DK) | 2017-08-23 | — | — | EP | disclosed |
| US-8927698-B2 | Method for the synthesis of a trisaccharide | GLYCOM A/S (DK) | 2015-01-06 | — | — | US | disclosed |
| US-20120116065-A1 | NOVEL METHOD FOR THE SYNTHESIS OF A TRISACCHARIDE | GLYCOM A/S (DK) | 2012-05-10 | — | — | US | disclosed |
| EP-2417144-A1 | SYNTHESIS OF 2 ' -O-FUCOSYLLACTOSE | Glycom A/S (DK) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010115935-A1 | SYNTHESIS OF 2 ' -O-FUCOSYLLACTOSE | GLYCOM A/S (DK) | 2010-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120116065-A1 | NOVEL METHOD FOR THE SYNTHESIS OF A TRISACCHARIDE | FUT6, FUT5, GALE | LGALS3 335/4885TACR1 3881/4885NPC1 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.